These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30742736)

  • 1. A cohort study of local excision followed by adjuvant therapy incorporating a contact X-ray brachytherapy boost instead of radical resection in 180 patients with rectal cancer.
    Smith FM; Pritchard DM; Wong H; Whitmarsh K; Hershman MJ; Sun Myint A
    Colorectal Dis; 2019 Jun; 21(6):663-670. PubMed ID: 30742736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study.
    Mitrea D; Barbet N; Pacé-Loscos T; Scouarnec C; Ben-Dhia S; Baron D; Mineur L; Évesque L; Durand-Labrunie J; Gérard JP; Baudin G; Doyen J
    Cancer Radiother; 2024 Aug; 28(4):323-332. PubMed ID: 39003168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 4. Contact radiotherapy boost in association with 'watch and wait' for rectal cancer: initial experience and outcomes from a shared programme between a district general hospital network and a regional oncology centre.
    Smith FM; Al-Amin A; Wright A; Berry J; Nicoll JJ; Sun Myint A
    Colorectal Dis; 2016 Sep; 18(9):861-70. PubMed ID: 26876570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
    Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of local excision followed by adjuvant therapy in early rectal cancer: are pT1 tumours the limit?
    Cutting JE; Hallam SE; Thomas MG; Messenger DE
    Colorectal Dis; 2018 Oct; 20(10):854-863. PubMed ID: 29992729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
    Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
    Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience.
    Sun Myint A; Smith FM; Gollins S; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman M; Pritchard DM
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):565-573. PubMed ID: 29229327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
    Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
    Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy].
    Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.
    Frin AC; Evesque L; Gal J; Benezery K; François E; Gugenheim J; Benizri E; Château Y; Marcié S; Doyen J; Gérard JP
    Eur J Cancer; 2017 Feb; 72():124-136. PubMed ID: 28027515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-centre analysis of adjuvant contact X-ray brachytherapy (CXB) in rectal cancer patients treated with local excision - Preliminary results of the CONTEM1 study.
    Dhadda A; Sun Myint A; Thamphya B; Hunter I; Hershman M; Gerard JP
    Radiother Oncol; 2021 Sep; 162():195-201. PubMed ID: 34329654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750).
    Sun Myint A; Rao C; Barbet N; Thamphya B; Pace-Loscos T; Schiappa R; Magné N; Martel-Lafay I; Mineur L; Deberne M; Zilli T; Dhadda A; Gerard JP
    Colorectal Dis; 2023 Nov; 25(11):2160-2169. PubMed ID: 37837240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer.
    Jeong JU; Nam TK; Kim HR; Shim HJ; Kim YH; Yoon MS; Song JY; Ahn SJ; Chung WK
    Radiat Oncol; 2016 Sep; 11(1):114. PubMed ID: 27595767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local excision and postoperative radiotherapy for distal rectal cancer.
    Benson R; Wong CS; Cummings BJ; Brierley J; Catton P; Ringash J; Abdolell M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1309-16. PubMed ID: 11483343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Watch and wait" approach in rectal cancer patients following complete clinical response to neoadjuvant chemoradiotherapy does not compromise oncologic outcomes.
    Neşşar G; Demirbağ AE; Mısırlıoğlu HC; Sezer S
    Turk J Gastroenterol; 2019 Nov; 30(11):951-956. PubMed ID: 31767549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage radical surgery after failed local excision for early rectal cancer.
    Friel CM; Cromwell JW; Marra C; Madoff RD; Rothenberger DA; Garcia-Aguílar J
    Dis Colon Rectum; 2002 Jul; 45(7):875-9. PubMed ID: 12130873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excluding the ischiorectal fossa irradiation during neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy followed by abdominoperineal resection decreases perineal complications in patients with lower rectal cancer.
    Song M; Geng J; Wang L; Li Y; Zhu X; Li X; Mi L; Wu A; Peng Y; Yao Y; Zhang Y; Wang H; Shi C; Cai Y; Wang W
    Radiat Oncol; 2019 Aug; 14(1):138. PubMed ID: 31382984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.